open access

Ahead of print
Research paper (original)
Published online: 2021-02-22
Get Citation

Skin-sparing and nipple-sparing mastectomy with positive sentinel node in patients with breast cancer

Piotr Kędzierawski, Artur Bocian, Ryszard Mężyk
DOI: 10.5603/NJO.a2021.0018

open access

Ahead of print
Original article
Published online: 2021-02-22

Abstract

Introduction Skin-sparing or nipple-sparing mastectomy is a method of surgical treatment that is increasingly used in the treatment of patients with breast cancer. More often women themselves decide or even ask to undergo this type of surgery. In our paper, we present the issue of combined treatment of sixty-two patients after nipple-sparing or skin-sparing mastectomy with a positive sentinel lymph node. Realization of this type of surgery has further consequences in adjuvant treatment policies. Material and Methods The group of previously untreated 62 women with positive sentinel lymph node was entered into this analysis. The individual plan of treatment was established for every patient by the multidisciplinary team according to the rules of a breast cancer unit. All patients were treated in the Holycross Cancer Centre in 2015-2018. Results The early results show that proper qualification and realization of oncological treatment is safe and effective, and severe complications not very often appeared. Conclusions Skin-sparing or nipple-sparing mastectomy is a method of surgical treatment that is increasingly used in the treatment of patients with breast cancer. It should be remembered that the qualification for this type of procedure should be careful and adjuvant treatment should be rationally planned. Our experience shows that it is an effective and safe method.

Abstract

Introduction Skin-sparing or nipple-sparing mastectomy is a method of surgical treatment that is increasingly used in the treatment of patients with breast cancer. More often women themselves decide or even ask to undergo this type of surgery. In our paper, we present the issue of combined treatment of sixty-two patients after nipple-sparing or skin-sparing mastectomy with a positive sentinel lymph node. Realization of this type of surgery has further consequences in adjuvant treatment policies. Material and Methods The group of previously untreated 62 women with positive sentinel lymph node was entered into this analysis. The individual plan of treatment was established for every patient by the multidisciplinary team according to the rules of a breast cancer unit. All patients were treated in the Holycross Cancer Centre in 2015-2018. Results The early results show that proper qualification and realization of oncological treatment is safe and effective, and severe complications not very often appeared. Conclusions Skin-sparing or nipple-sparing mastectomy is a method of surgical treatment that is increasingly used in the treatment of patients with breast cancer. It should be remembered that the qualification for this type of procedure should be careful and adjuvant treatment should be rationally planned. Our experience shows that it is an effective and safe method.

Get Citation

Keywords

breast cancer; skin-sparing mastectomy; nipple-sparing mastectomy; combined treatment

About this article
Title

Skin-sparing and nipple-sparing mastectomy with positive sentinel node in patients with breast cancer

Journal

Nowotwory. Journal of Oncology

Issue

Ahead of print

Article type

Research paper (original)

Published online

2021-02-22

DOI

10.5603/NJO.a2021.0018

Keywords

breast cancer
skin-sparing mastectomy
nipple-sparing mastectomy
combined treatment

Authors

Piotr Kędzierawski
Artur Bocian
Ryszard Mężyk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl